ON DEMAND 2024 APRN Midwest Conference - New and Old Long Acting Injectables for Substance Use Disorders
CE Information
1.0 contact hour (1.0 pharmacology)Completion Time
1 hourAvailable Until
December 31, 2025
Navigate
Overview
Clinical Topics
PharmacologyLong acting injectables (LAIs) for substance use disorders (SUDs) represent a promising approach to treatment that offers several advantages over traditional oral or sublingual formulations. These injectables typically provide sustained release of medication over an extended period, ranging from weeks to months, which can improve stability in treatment, and reduce the risk of recurrence of substance use and overdose. In this presentation we will review the safety and efficacy of the use of long acting injectables (LAIs) for the treatment of substance use disorders, such as Opiate Use Disorder (OUD) and Alcohol Use Disorder (AUD). We will discuss the various clinical indications, available formulations, MOA, side effects, contraindications, storage, and follow-up.
Learning Objectives
-
Understanding Long-Acting Injectable Medications for SUD: Equip healthcare providers with comprehensive knowledge of the available long-acting injectable (LAI) formulations for treating substance use disorders (SUD), including their safety, efficacy, and clinical indications.
-
Application of LAIs in Clinical Practice: Develop skills in administering and managing patients on long-acting injectables such as Buprenorphine (Sublocade and Brixadi) and Naltrexone (Vivitrol), focusing on correct dosing, storage requirements, and follow-up protocols to optimize patient outcomes.
-
Addressing Barriers and Enhancing Patient Compliance: Train healthcare providers to effectively address the barriers to accessing LAI treatments for SUD, including understanding regulatory requirements and utilizing provider resources to enhance patient compliance and support.
Learning Outcome Evaluation: Participants will state one thing they learned from the program and how they will implement it into their practice.
Speakers
Dr. Danielle Rodriguez is a Family Nurse Practitioner who specialized in Addiction and Behavioral Health at Mile Square L.P. Johnson Clinic in Rockford, IL. She graduated with a Doctor of Nursing Practice from the University of Illinois Chicago in 2022. She is a member of Illinois Society for Advance Practice Nurses (ISAPN), American Society of Addiction Medicine (ASAM), and American Association of Nurse Practitioners (AANP).Areas of interest include the treatment of substance use disorders, harm reduction, trauma-focused care, equitable care of justice involved populations, universal screening of Adverse Childhood Experiences (ACE’s) and the treatment of mental across the lifespan.
CE Information
This activity offers 1.0 contact hour (1.0 pharmacology) to attendees.
Accredited by Illinois Nurses Foundation is approved as a provider of nursing continuing professional development by the Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.
The Illinois Nurses Foundation and the Illinois Society for Advanced Practice Nursing jointly provided this program.
Disclosures
To earn contact hours, learners must watch the entire webinar and submit an evaluation to receive the digital certificate after the session.
There are no relevant financial relationships with ineligible companies for those involved with the ability to control the content of this activity
Activity Content
Registration to this activity includes access to the following supporting materials.
- New and Old Long Acting Injectables for Substance Use Disorders (Size: 1.11 MB)
Duration: about 1 hour | Quality: HD
4 questions
Access your certificate